SK142495A3 - Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use - Google Patents
Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use Download PDFInfo
- Publication number
- SK142495A3 SK142495A3 SK1424-95A SK142495A SK142495A3 SK 142495 A3 SK142495 A3 SK 142495A3 SK 142495 A SK142495 A SK 142495A SK 142495 A3 SK142495 A3 SK 142495A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- carbazole
- ylmethyl
- formula
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
PCT/EP1994/001613 WO1994027989A1 (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives with 17,20-lyase-inhibiting activity |
Publications (1)
Publication Number | Publication Date |
---|---|
SK142495A3 true SK142495A3 (en) | 1996-06-05 |
Family
ID=10736007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1424-95A SK142495A3 (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0699196A1 (fi) |
JP (1) | JPH08510455A (fi) |
CN (1) | CN1126473A (fi) |
AU (1) | AU6928794A (fi) |
BG (1) | BG100154A (fi) |
CA (1) | CA2162921A1 (fi) |
CZ (1) | CZ305195A3 (fi) |
FI (1) | FI955587A (fi) |
GB (1) | GB9310635D0 (fi) |
HU (1) | HUT73790A (fi) |
IL (1) | IL109703A0 (fi) |
NO (1) | NO954681D0 (fi) |
OA (1) | OA10195A (fi) |
PE (1) | PE31195A1 (fi) |
PL (1) | PL311702A1 (fi) |
SK (1) | SK142495A3 (fi) |
TW (1) | TW279866B (fi) |
WO (1) | WO1994027989A1 (fi) |
ZA (1) | ZA943494B (fi) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ273681A (en) * | 1993-09-30 | 1996-09-25 | Yamanouchi Pharma Co Ltd | Fluoroenylmethylazole derivatives (including tricyclic ring systems where the middle ring is heterosubstituted) |
WO1996014090A1 (en) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
EP0820989A4 (en) * | 1995-03-01 | 1998-05-06 | Yamanouchi Pharma Co Ltd | IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES |
EP0974584B1 (en) * | 1997-02-21 | 2003-01-15 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
ES2260303T3 (es) | 2000-11-17 | 2006-11-01 | Takeda Pharmaceutical Company Limited | Derivados de imidazol, metodo para su produccion, y su uso. |
US6960586B2 (en) | 2000-11-20 | 2005-11-01 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, process for their preparation and their use |
US7067537B2 (en) | 2000-12-08 | 2006-06-27 | Takeda Pharmaceutical Company Limited | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
BRPI0611705A2 (pt) * | 2005-06-24 | 2016-11-16 | Lilly Co Eli | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de composto |
US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
ES2475945T3 (es) | 2009-06-26 | 2014-07-11 | Novartis Ag | Derivados imidazolidin-2 -ona 1,3-disustituida como inhibidores de CYP 17 |
AU2011212813B2 (en) | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
DK2568806T3 (en) | 2010-05-12 | 2016-08-15 | Radius Health Inc | therapy Programs |
AU2011285724B2 (en) | 2010-08-04 | 2015-01-22 | Pellficure Pharmaceuticals, Inc. | Combination therapy for the treatment of prostate carcinoma |
CN103108871B (zh) | 2010-09-16 | 2014-09-10 | 诺华股份有限公司 | 17α-羟化酶/C17,20-裂合酶抑制剂 |
JP5965909B2 (ja) | 2010-09-28 | 2016-08-10 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
BR112013027395A2 (pt) | 2011-04-28 | 2017-01-17 | Novartis Ag | inibidores de 17alfa-hidroxilase/c17,20-liase |
US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
WO2014158875A1 (en) | 2013-03-14 | 2014-10-02 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
EP3834824A1 (en) | 2014-03-28 | 2021-06-16 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
AU2015314772B2 (en) | 2014-09-12 | 2020-02-27 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
CA3027563A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
CA3044812A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-20 FI FI955587A patent/FI955587A/fi not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB9310635D0 (en) | 1993-07-07 |
CZ305195A3 (en) | 1996-06-12 |
EP0699196A1 (en) | 1996-03-06 |
CA2162921A1 (en) | 1994-12-08 |
FI955587A0 (fi) | 1995-11-20 |
WO1994027989A1 (en) | 1994-12-08 |
OA10195A (en) | 1996-12-18 |
PE31195A1 (es) | 1995-10-18 |
TW279866B (fi) | 1996-07-01 |
CN1126473A (zh) | 1996-07-10 |
BG100154A (en) | 1996-07-31 |
FI955587A (fi) | 1995-11-20 |
ZA943494B (en) | 1995-01-23 |
JPH08510455A (ja) | 1996-11-05 |
IL109703A0 (en) | 1994-08-26 |
PL311702A1 (en) | 1996-03-04 |
NO954681L (no) | 1995-11-20 |
HUT73790A (en) | 1996-09-30 |
NO954681D0 (no) | 1995-11-20 |
HU9503321D0 (en) | 1996-01-29 |
AU6928794A (en) | 1994-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK142495A3 (en) | Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use | |
EP3040331B1 (en) | Tetrahydrocyclopentapyrrole derivative and preparation method therefor | |
AU780989B2 (en) | 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anesthetic activity | |
SK277923B6 (en) | 3-imidazolymethyl-1,2,3,9-tetrahydro-4h-carbazole-4-on derivatives, method of their preparation and pharmaceutical agents containing this agents | |
SK5462003A3 (en) | Indolylmaleimide derivatives, method for the preparation thereof and pharmaceutical composition comprising same | |
SU1549485A3 (ru) | Способ получени производных 6-метиленандроста-1,4-диен-3,17-диона | |
EP0816338B1 (en) | 3-(bis-substituted-phenylmethylene)oxindole derivatives | |
EP0445073A1 (de) | Benzofurane | |
US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
HU193351B (en) | Process for production of 1,2,4-triasole carbamates and their acid additioned salts | |
EP0170861B1 (de) | 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
US7488743B2 (en) | Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof | |
CA2557942A1 (fr) | Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique | |
EP1809602B1 (en) | Indole derivatives useful as progesterone receptor modulators | |
US4785103A (en) | 2-oxa- or -aza-pregnane compounds | |
EP0457716A1 (de) | Naphthalinderivate | |
NO174928B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive enoletere av 6-klor-4-hydroksy-2-metyl-N-(2-pyridyl)-2H-tieno(2,3-e)-1,2-tiazin-3-karboksylsyreamid-1,1-dioksyd | |
HU198296B (en) | Process for producing new 2-pyridyl acetic acid derivatives and pharmaceutical compositions comprising same | |
HU179980B (en) | Process for preparing substituted steroid-spiro-oxazolidinone derivatives | |
EP0574992A1 (en) | 5-(1,2,4-Triazol-1-ylmethyl)-3H-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors | |
HRP940940A2 (en) | Chemical compounds | |
EP0654265A1 (en) | Aromatase-inhibiting composition containing azole derivative | |
MXPA98004819A (en) | Gonadotrop liberating hormone antagonists | |
CZ20001145A3 (cs) | Tricyklické triazolobenzazepinové deriváty | |
JPS58159468A (ja) | 新規な1位置換3−アミノインダゾ−ル誘導体およびその製造法 |